CAR T Moving Forward

Recent scientific developments, real clinical practice changes, and what is in store for EU patients

Speaker

Elias Jabbour, MD

The University of Texas MD Anderson Cancer Center

Moderator

Chadi Nabhan, MD, MBA, FACP

Aptitude Health

Look Inside This Report

Download a sample of this report and start discovering the insights.

Topics Covered in the Report

 

  • Integration of CAR T therapy within the community
  • CAR T therapy within the setting of acute lymphoblastic leukemia (ALL), diffuse large B-cell lymphoma (DLBCL), and multiple myeloma (MM)

GEOGRAPHIC REPRESENTATION & CONTENT DEVELOPMENT

 

  • A moderated roundtable discussion focusing on CAR T-cell therapy was held on August 25, 2019, in Washington, DC, US
  • Disease state and data presentations were developed in conjunction with an expert from MD Anderson Cancer Center
  • The group of advisors comprised 10 community oncologists from the Northeast, US
  • Data collection was accomplished through use of audience response system questioning and moderated discussion

Explore Available and Upcoming Insight Reports

View Reports